Observational analysis revealed that adjuvant chemotherapy improves survival in non-small cell lung cancer, suggesting importance of tailored strategies based on prognostic factors.
Key Points
Survival improves with adjuvant chemotherapy, showing significance in non-small cell lung cancer treatment.
The analysis included 191 patients with T4 non-small cell lung cancer, assessing long-term survival variation.
Kaplan–Meier and Cox regression analyses characterized survival outcomes based on T4 subgroups and nodal status.
Results indicate that tailored surgical strategies are crucial for improving patient prognoses in T4 lung cancer.